Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ
JNJ
J&J's patient assistance program suffers data breach, IBM says
Fierce Pharma
Thu, 09/7/23 - 09:43 am
JNJ
Janssen
IBM
patient assistance programs
cybersecurity
J&J sends blood pressure drug back to Idorsia
BioPharma Dive
Wed, 09/6/23 - 11:54 am
Idorsia
JNJ
aprocitentan
hypertension
Despite price drops, J&J gets little reprieve from TB drug saga
Medical Marketing and Media
Wed, 09/6/23 - 10:12 am
JNJ
tuberculosis
generics
bedaquiline
Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?
Motley Fool
Thu, 08/31/23 - 11:01 am
Medicare
JNJ
drug pricing
Johnson & Johnson's spinoff of Kenvue provides $13.2B in potential M&A firepower
Fierce Pharma
Wed, 08/30/23 - 11:29 pm
JNJ
M&A
consumer health
Kenvue
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Medicare
HHS
Pfizer
Bristol Myers Squibb
Eli Lilly
Boehringer Ingelheim
AstraZeneca
AbbVie
Novo Nordisk
JNJ
drug pricing
5 of the best places to work in pharma, according to employees
Pharma Voice
Tue, 08/29/23 - 11:32 am
Glassdoor
Merck
JNJ
Pfizer
GSK
Sanofi
J&J ends R&D at Janssen's infectious disease and vaccine unit
Fierce Biotech
Wed, 08/23/23 - 05:40 pm
JNJ
infectious disease
vaccines
R&D
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
Wed, 08/23/23 - 11:11 am
patent cliff
patents
Takeda
Vyvanse
Pfizer
Eraxis
JNJ
Stelara
Merck
Isentress
Eiger Pharmaceuticals
Zokinvy
Astellas
Myrbetriq
Novartis
Entresto
Amgen
Otzela
Regeneron, J&J Win HHS Funding to Develop Next-Gen COVID Products
BioSpace
Wed, 08/23/23 - 09:54 am
HHS
Regeneron
JNJ
COVID-19
funding
Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca
Yahoo/Zacks.com
Tue, 08/22/23 - 09:58 am
earnings
Eli Lilly
JNJ
Novo Nordisk
Novartis
AstraZeneca
Behind the FDA Submission: How J&J Won a Key Approval in AF Ablation
Medical Devices and Diagnostics Industry
Tue, 08/22/23 - 09:56 am
JNJ
Medtech
Biosense Webster
FDA
cardiac ablation
Janssen granted additional European Commission approval for bispecific antibody
Biopharma Reporter
Tue, 08/22/23 - 09:54 am
Janssen
JNJ
bispecific antibodies
Europe
relapsed or refractory multiple myeloma
Johnson & Johnson to keep a 9.5% stake in consumer health spinoff Kenvue stake after exchange offer
Fierce Pharma
Mon, 08/21/23 - 06:55 pm
JNJ
consumer health
spinoff
Kenvue
J&J’s Abiomed updates labeling for certain Impella heart pumps in Class I safety event
Fierce Biotech
Sun, 08/20/23 - 05:15 pm
Medtech
JNJ
Abiomed
Impella
product recalls
device recalls
J&J joins PARP rivals with narrow FDA clearance in prostate cancer
BioPharma Dive
Mon, 08/14/23 - 10:18 am
JNJ
Akeega
BRCA-mutated prostate cancer
PARP inhibitors
FDA
J&J bags first FDA approval for a GPRC5D drug
Pharmaphorum
Thu, 08/10/23 - 09:52 am
JNJ
FDA
GPRC5D
Talvey
relapsed or refractory multiple myeloma
Johnson & Johnson's Talc Problems Aren't Going Away
Motley Fool
Wed, 08/9/23 - 10:05 am
JNJ
talc
legal
J&J's Stelara settlement streak rolls on with Fresenius Kabi, Formycon deal
Fierce Pharma
Mon, 08/7/23 - 10:52 am
JNJ
Stelara
patents
legal
Formycon
Fresenius Kabi
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
clinical trials
Sarepta Therapeutics
DMD
Elevidys
Bridge Bio
ATTR-CM
acoramidis
Sanofi
Merck KGaA
MS
tolebrutinib
Pfizer
obesity
danuglipron
Novo Nordisk
Ozempic
Verve Therapeutics
heterozygous familial hypercholesterolemia
Roche
lung cancer
tiragolumab
Vertex Pharmaceutical
VS-548
pain
JNJ
Bristol Myers Squibb
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »